Jefferson Abington Hospital is the flagship hospital of Jefferson Health–Abington, located in Abington Township, Montgomery County, Pennsylvania, in the northern suburbs of Philadelphia.

There are 665 beds in Abington Hospital-Jefferson Health.

During the past decade, Abington Hospital-Jefferson Health conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 5 clinical trials were completed, i.e. on average, 71.4% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Abington Hospital-Jefferson Health" #1 sponsor was "Abington Memorial Hospital" with 2 trials, followed by "Sidney Kimmel Cancer Center at Thomas Jefferson University" with 2 trials sponsored, "Boston Scientific Corporation" with 1 trials sponsored, "Ferring Pharmaceuticals" with 1 trials sponsored and "Guerbet" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Abington Hospital-Jefferson Health" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator and "University of Calgary" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Abington Hospital-Jefferson Health" are "Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities" (1 trials), "Adult Acute Myeloid Leukemia With Del(5q)" (1 trials), "Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)" (1 trials), "Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)" (1 trials) and "Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)" (1 trials). Many other conditions were trialed in "Abington Hospital-Jefferson Health" in a lesser frequency.

Most popular intervention types in "Abington Hospital-Jefferson Health" are "Drug" (5 trials), "Device" (2 trials), "Biological" (1 trials), "Combination Product" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Abdominal Closure Bundle" (1 trials), "Azacitidine" (1 trials), "Bupivacaine" (1 trials), "Cisplatin" (1 trials) and "Furoscix Infusor" (1 trials). Other intervention names were less common.

The vast majority of trials in "Abington Hospital-Jefferson Health" are 7 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Abington Hospital-Jefferson Health". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Abington Hospital-Jefferson Health, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Abington Hospital-Jefferson Health, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".